Benzinga | Aug 17, 2021 11:16AM EDT

RedHill Biopharma US Patent & Trademark Office Abstract Shows Co. Granted Patent For 'Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine'

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FP[]637&f=G&l=50&d=PTXT&p=133&S1=20210817&OS=20210817&RS=20210817